Loading
SEC Form 13F · Q2 2026
Suvretta Capital portfolio
Aaron Cowen · SUVRETTA CAPITAL MANAGEMENT, LLC · CIK 0001569064
Latest 13F for the quarter ended Jun 30, 2026, filed Aug 14, 2026, compared with the quarter ended Mar 31, 2026.
Reported 13F value$5.5B
Holdings96
Top 10 concentration38.8%
New positions22
Added to25
Reduced17
Closed15
What changed in Q2 2026
Estimated trade value from reported units and period-end values
New positions
Added to
Reduced
Closed
Holdings, Q2 2026
96 positions by reported value · includes 1 option positions
| Holding | Portfolio weight | Reported value | Shares / units | Change vs prior quarter |
|---|---|---|---|---|
| SPYSTATE STR SPDR S&P 500 ETF T · TR UNIT · PUT | 12.97% | $709.4M | 950,000 | +171.4% |
| MANEVERADERMICS INC · COMMON STOCK | 9.37% | $512.5M | 4,168,970 | Unchanged |
| ARQTARCUTIS BIOTHERAPEUTICS INC · COM | 5.96% | $326.1M | 12,437,000 | +0.9% |
| LEGNLEGEND BIOTECH CORP · SPONSORED ADS | 3.73% | $204.2M | 7,070,000 | -6.7% |
| PVLAPALVELLA THERAPEUTICS INC NE · COM |
Source: SEC Form 13F filings (latest filing on sec.gov). Information and analytics, not investment advice. Holdings are reported as of the quarter end, not live positions; reported 13F value covers securities listed on Form 13F and is not the fund's total assets under management.